These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

753 related items for PubMed ID: 8625303

  • 21. Von Hippel-Lindau disease.
    Sano T, Horiguchi H.
    Microsc Res Tech; 2003 Feb 01; 60(2):159-64. PubMed ID: 12539169
    [Abstract] [Full Text] [Related]

  • 22. von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids.
    Lieubeau-Teillet B, Rak J, Jothy S, Iliopoulos O, Kaelin W, Kerbel RS.
    Cancer Res; 1998 Nov 01; 58(21):4957-62. PubMed ID: 9810005
    [Abstract] [Full Text] [Related]

  • 23. Molecular targeting of VHL gene pathway in clear cell kidney cancer.
    Linehan WM.
    J Urol; 2003 Aug 01; 170(2 Pt 1):593-4. PubMed ID: 12853837
    [No Abstract] [Full Text] [Related]

  • 24. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
    Stratmann R, Krieg M, Haas R, Plate KH.
    J Neuropathol Exp Neurol; 1997 Nov 01; 56(11):1242-52. PubMed ID: 9370235
    [Abstract] [Full Text] [Related]

  • 25. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.
    Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ.
    Oncogene; 2000 Dec 14; 19(54):6297-305. PubMed ID: 11175344
    [Abstract] [Full Text] [Related]

  • 26. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
    Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG.
    Hum Mol Genet; 2001 May 01; 10(10):1019-27. PubMed ID: 11331612
    [Abstract] [Full Text] [Related]

  • 27. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B.
    Cancer Surv; 1995 May 01; 25():219-32. PubMed ID: 8718521
    [Abstract] [Full Text] [Related]

  • 28. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY, Poellinger L, Walker CL.
    Cancer Res; 2003 May 15; 63(10):2675-80. PubMed ID: 12750296
    [Abstract] [Full Text] [Related]

  • 29. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.
    Lee S, Neumann M, Stearman R, Stauber R, Pause A, Pavlakis GN, Klausner RD.
    Mol Cell Biol; 1999 Feb 15; 19(2):1486-97. PubMed ID: 9891082
    [Abstract] [Full Text] [Related]

  • 30. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
    Kaelin WG.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
    Iliopoulos O, Levy AP, Jiang C, Kaelin WG, Goldberg MA.
    Proc Natl Acad Sci U S A; 1996 Oct 01; 93(20):10595-9. PubMed ID: 8855223
    [Abstract] [Full Text] [Related]

  • 34. Tumour suppression by the human von Hippel-Lindau gene product.
    Iliopoulos O, Kibel A, Gray S, Kaelin WG.
    Nat Med; 1995 Aug 01; 1(8):822-6. PubMed ID: 7585187
    [Abstract] [Full Text] [Related]

  • 35. The von Hippel-Lindau tumor suppressor gene protects cells from UV-mediated apoptosis.
    Schoenfeld AR, Parris T, Eisenberger A, Davidowitz EJ, De Leon M, Talasazan F, Devarajan P, Burk RD.
    Oncogene; 2000 Nov 30; 19(51):5851-7. PubMed ID: 11127815
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells.
    Masuda K, Ono M, Okamoto M, Morikawa W, Otsubo M, Migita T, Tsuneyoshi M, Okuda H, Shuin T, Naito S, Kuwano M.
    Int J Cancer; 2003 Jul 20; 105(6):803-10. PubMed ID: 12767066
    [Abstract] [Full Text] [Related]

  • 38. VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma.
    Chan CC, Vortmeyer AO, Chew EY, Green WR, Matteson DM, Shen DF, Linehan WM, Lubensky IA, Zhuang Z.
    Arch Ophthalmol; 1999 May 20; 117(5):625-30. PubMed ID: 10326959
    [Abstract] [Full Text] [Related]

  • 39. pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation.
    Iliopoulos O, Ohh M, Kaelin WG.
    Proc Natl Acad Sci U S A; 1998 Sep 29; 95(20):11661-6. PubMed ID: 9751722
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.